RARA and Alzheimer disease: Small lipophilic ligands for RARs generally cross the BBB [28, 116], while RAR ligands like Am80 [117] and acitretin [118] have demonstrable therapeutic action in AD mouse models, indicative of their capacity to cross the BBB.